Intervention Study Investigating the Effect of a Phospholipid Drink on Cognitive Performance in 6-8 Year Old School Children
NCT ID: NCT03705572
Last Updated: 2018-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
165 participants
INTERVENTIONAL
2014-05-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of a Phospholipid Drink on Cognitive Performance Under Acute Stress
NCT01879813
Investigating the Effects of Dietary Phospholipids on Measures of Human Brain Health and Psychological Wellbeing
NCT06107075
Phospholipid-rich Dairy Extract for Cognitive Function
NCT07011680
The Cognitive Effects of 6- and 12-weeks Administration of a Food Supplement Containing Phosphatidylserine in Healthy Children Aged 8 to 12 Years
NCT05177978
Investigating the Effects of Dietary Phospholipids on Stress Reactivity and Recovery
NCT06109922
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dietary Supplement: Phospholipid drink.
Participant in an intervention parallel group consumed a drink with added phospholipids (Lacprodan PL20).
Lacprodan PL20
Milk protein concentrate that is high in phospholipid content (min 16%).
Dietary Supplement: Placebo milk drink.
Participant in an intervention parallel group consumed a drink without added phospholipids.
Placebo
Placebo milk drink.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lacprodan PL20
Milk protein concentrate that is high in phospholipid content (min 16%).
Placebo
Placebo milk drink.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness to consume milk drinks during the study determined by a score of \>5 on a taste testing Likert scale for at least one flavour of the milk drinks.
* Ability to follow verbal and simple written instructions in English.
* Normal vision, with appropriate corrective lenses if required.
* Ability to understand cognitive testing instructions and responding requirements.
Exclusion Criteria
* Colour blindness.
* Behavioural difficulties or attention disorders (e.g. Attention Deficit Hyperactivity Disorder).
* Learning disabilities that interfere with the ability to understand written or verbal communications.
* Inability to understand the objective of the cognitive tests, or carry out the tests.
* Any food allergies or intolerances (e.g. lactose intolerance).
* Acute illness, or feelings of unwell, within the week prior to testing.
* Current administration of any psychotropic medication or supplementation in the month prior to testing, or during testing.
* Hearing impairment that precludes the ability to follow verbal instructions.
* Children already receiving milk at school unless parents are willing to substitute current milk with the study milk.
6 Years
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arla Foods
INDUSTRY
University of Leeds
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof Louise Dye
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Louise Dye, PhD
Role: PRINCIPAL_INVESTIGATOR
Professor of Nutrition & Behaviour; Lead for Strategic Development.
Clare Lawton, PhD
Role: PRINCIPAL_INVESTIGATOR
Associate Professor of Nutrition & Behaviour.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Arla02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.